Maintaining ‘warm base’ capacity for pandemic preparedness

The COVID-19 pandemic put immense pressure on vaccine manufacturing facilities to rapidly scale up processes to meet demand—could warm base facilities be a solution for future pandemics? Casey Nevins, Assistant Editor, Vaccine Insights, speaks with Kilian Mullett, Senior Director of Commercial Supply Strategies, Pfizer, about challenges and solutions associated with establishing and maintaining a warm base vaccine manufacturing facility.

Please enter your email to access content Read now